Relapsing malaria infection acquired in Kenya.
An American physician-traveler to East Africa presented with manifestations of cerebral malaria and was treated with intravenous quinidine for chloroquine-resistant falciparum malaria. He later relapsed with Plasmodium ovale infection, despite previous primaquine therapy. Treatment of chloroquine-resistant malaria is discussed. The difficulty in diagnosing P. ovale infections and the predominance of this malaria species over P. vivax in East Africa are reviewed.
Patterson
J E
JE
Bia
F J
FJ
Miller
K
K
McPhedran
P
P
D000349:Africa; D002738:Chloroquine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum; D011319:Primaquine / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D012008:Recurrence; D014195:Travel
D002738:Chloroquine; D011802:Quinidine; D011319:Primaquine